What is it about?
Investigated inflammatory Bowel Disease (IBD) serological markers in Ankylosing spondylitis (AS) patients without IBD.
Featured Image
Why is it important?
These research corroborate a pathophysiological link between AS and IBD
Read the Original
This page is a summary of: pANCA, ASCA, and OmpC Antibodies in Patients with Ankylosing Spondylitis without Inflammatory Bowel Disease, The Journal of Rheumatology, September 2010, The Journal of Rheumatology,
DOI: 10.3899/jrheum.100269.
You can read the full text:
Contributors
The following have contributed to this page
